Diagonal Bio announces that it is exploring financing options

, , , ,
Diagonal Bio AB ("Diagonal Bio" or "the Company") today announces that the Board of Directors of the Company has engaged financial and legal advisors and decided to explore potential financing alternatives to secure the Company’s ongoing…

Diagonal announces first pilot test at a stud with LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces a partnership with Gocksta Stud (Gocksta Stuteri), led by Anne-Sophie Thiam, to conduct a three-month pilot study, which begins immediately. This pilot test will evaluate LAMPlify’s…

Diagonal Bio AB Third Quarter Report (Q3 2024)

, , , , , , ,
“One of the most exciting developments is our effort into a new application of our technology LAMPlify®—this time in the domain of swine diseases.”Summary of Q3 report 20242024-07-01 — 2024-09-30 (July — September…

Diagonal Bio announces pilot test of LAMPlify® at Norwegian University of Life Sciences

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces the commencement of a six-month pilot test of its point-of-care diagnostic platform, LAMPlify®, at the Norwegian University of Life Sciences (NMBU) in Ås. The pilot,…

Diagonal Bio will present LAMPlify® at a partnered event for trainers at Jägersro

, ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") will be participating in a partnered event with Svensk Galopp, at Jägersro on November 7, 2024. The Company’s diagnostic platform, LAMPlify®, will be introduced to a select…

Diagonal Bio announces successful external validation of LAMPlify® for viruses in pigs

, , , ,
Diagonal Bio AB (publ) (“Diagonal” or “the Company”) announces successful results of a recent pilot study conducted by the Centre for Diagnostics at DTU Health Technology. The study evaluated the performance of the LAMPlify®…

Hunneberga Horse Stable to conduct pilot test of LAMPlify®

, , , ,
Diagonal Bio AB (publ) ("Diagonal Bio" or "the Company") announces that Hunneberga Horse Stable (Hunneberga Hästgård) and Tomas Hammar, showjumping trainer and CEO at Hunneberga Horse Stable, has initiated a partnership with Diagonal…

Horse trainer Daniel Redén at StallZet will conduct a pilot with LAMPlify®

, , , ,
Diagonal Bio AB (publ) (“Diagonal Bio” or “the Company”) has partnered with StallZet and Daniel Redén, one of Sweden's leading horse trotting training facilities, to conduct a pilot test using LAMPlify® to…

Diagonal Bio AB’s warrant exercise registered at the Swedish Companies Registration Office

, , ,
Diagonal Bio AB ("Diagonal" or the "Company") today announces that the new shares from the exercise of warrants of series TO 1 have been registered with the Swedish Companies Registration Office.On 26 September 2024, the exercise period for…

Diagonal Bio AB announces the outcome of the exercise of warrants of series TO 1

, , ,
On September 26, 2024, the exercise period for Diagonal Bio AB's ("Diagonal" or the "Company") warrants of series TO 1 ("TO 1") ended. A total of 77.794 warrants of series TO 1 have been exercised to subscribe for 77.794 shares, corresponding…